01.02.23 -- How To Overcome Recruitment Challenges Of Black & Rural Patients

Sponsors, sites, and CROs are generally required to conduct a successful clinical trial. But those three entities do not always see eye-to-eye when issues arise. Whether it’s site payments, patient recruitment, or clinical technology adoption, disagreements can and do occur.

An increasing number of clinical trials are using multiple trial sites. Thankfully, there are several things you can do to prevent headaches and achieve peace of mind. Find out here.

Sanofi has adopted a patient informed research and development model within the organization. The goal of the model is to work with patients, patient groups, and patient communities to understand the concerns of patients and ensure their voices are heard throughout the company. Today, Sanofi’s development programs are 100% informed by individuals from the patient communities and 100% of Phase 2 and Phase 3 trials have a remote capability built into them.

Delve into the challenges in rare disease and how they are only heightened for younger patient populations, where outcome measures and dosages need to be considered appropriately.

Patient recruitment for clinical trials is difficult and can cause many studies to be delayed or canceled. Two groups that are particularly difficult to recruit are patients of color and those living in remote and rural areas of the country. In those two instances, overcoming recruitment barriers can prove to be particularly difficult.

Explore how to address biases that thwart diversity and inclusion in dementia clinical research in this blog.

Whether you are new to research or an established site, explore how PatientSelect accelerates research and optimizes study outcome and experiences for all stakeholders.